Log in


Current Advocacy Campaignes

The MedAccessBC coalition of patient groups (common & rare diseases) which CanPKU+ belongs to has planned a public awareness & advocacy campaign in first part of 2024 to address BC's need to Expand Public Medication Coverage

Homocystinuria (HCU)- Did you know that only 5 provinces include Homocysinuria on the Newborn Screen Panel? We are working to improve this! Check out the Homocystinuria-Newborn Screening page.

CanPKU+ has a working group which are creating a submission to Health Canada to contribute to the regulatory modernization of foods catering to special dietary needs including medical foods.

Kuvan - We are currently looking for advocates in AB, SK and ON (primarily, but will accept from nationwide) to help with the continued fight against the regulations regarding Kuvan approval in the province.

Kuvan was approved for use but still not covered in some provinces in Canada

Kuvan Fact Sheet in Canada based on Jan 2023

Upcoming events

  • No upcoming events

Congratulations to our members who have successfully completed a course on advocacy

Samantha (HCU Adult, HCU Chair person)

Advocacy Resources

Infographic: How new laws and regulations are created Check out this link from the Government of Canadan

Advocacy Successes

Our voices have been heard! The following is a list of ways that CanPKU+, patients and families have come together to encourage change.

2021 © Copyright CanPKU.ORG

Uh oh! Looks like we have failed to update this recently! Stay tuned for our Advocacy Success updates

2016 Patient submissions to the Common Drug Review re Kuvan
Funding of Kuvan for indigenous patients by Health Canada – 2016
2015 - Funding of low protein foods and extra formulas in PEI 

2015 - Funding of low protein foods for adults by Manitoba – children were already covered
2014 Funding of low protein foods by BC

2013 - Funding of Kuvan by Ontario, Saskatchewan & Quebec 

2012 - Funding of low protein foods by Saskatchewan 
Funding of low protein foods by Saskatchewan – 2012

2010 Patient submissions to the Common Drug Review re Kuvan
Averting a crisis in 2003 when Ontario wanted to take formulas away from adult patients.  This was before CanPKU existed but was the impetus for the formation of the organization

Advocacy Outreaches


LETTER Rawson-Adams: McMillan and Campbell believe that Canada needs a regulatory framework for the introduction of orphan drugs for rare disorders. We agree. However, the need is unlikely to be met in the foreseeable future because, in October 2017, the present federal government deleted from the Health Canada website, without notice or consultation, all references to the previous government’s 2012 Orphan Drug Regulatory Framework. Read the full Letter here


260 Adelaide Street East, #180
Toronto, ON, M5A 1N1, Canada
Toll Free: 1-877-226-7581

Powered by Wild Apricot Membership Software